Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Sutro Biopharma Inc (STRO)

Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sutro Biopharma Inc 111 Oyster Point Blvd South San Francisco CA 94080 USA

www.sutrobio.com P: 650-881-6500

Description:

Sutro Biopharma Inc. develops and manufactures pharmaceutical products. The Company provides antibody drug conjugate and multi-specific antibody-based therapeutics for cancer therapy. Its product pipeline consists of STRO-001 and STRO-002 which are in clinical stage. Sutro Biopharma Inc. is based in South San Francisco, California.

Key Statistics

Overview:

Market Capitalization, $K 239,153
Enterprise Value, $K 173,943
Shares Outstanding, K 62,442
Annual Sales, $ 153,730 K
Annual Net Income, $ -106,790 K
Last Quarter Sales, $ 113,720 K
Last Quarter Net Income, $ 31,070 K
EBIT, $ -89,280 K
EBITDA, $ -91,540 K
60-Month Beta 1.09
% of Insider Shareholders 6.90%
% of Institutional Shareholders 96.99%
Float, K 58,134
% Float 93.10%
Short Volume Ratio 0.27

Growth:

1-Year Return -25.20%
3-Year Return -80.15%
5-Year Return -66.70%
5-Year Revenue Growth 300.13%
5-Year Earnings Growth 68.84%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.42 on 03/25/24
Latest Earnings Date 05/20/24
Earnings Per Share ttm -1.79
EPS Growth vs. Prev Qtr 151.85%
EPS Growth vs. Prev Year 168.85%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

STRO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -71.42%
Return-on-Assets % -24.92%
Profit Margin % -69.47%
Debt/Equity 0.03
Price/Sales 1.60
Price/Cash Flow N/A
Price/Book 1.52
Book Value/Share 2.46
Interest Coverage -6.92
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar